291 results on '"Poveda, Andres"'
Search Results
2. Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
3. Efectividad y seguridad en vida real de nivolumab en pacientes con linfoma de hodgkin clásico en recaída o refractario
4. Presencia de buenas prácticas de humanización en la atención a los pacientes con enfermedades raras en los servicios de farmacia
5. [Translated article] Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia
6. Consenso de recomendaciones para la mejora de la coordinación asistencial inter e intra-centros en el abordaje de la hemofilia
7. Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup
8. High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis
9. 4CPS-070 Evaluation of avoided cost in clinical trials with immunotherapy in lung cancer
10. Population-adjusted indirect treatment comparison of the SOLO1 and PAOLA-1/ENGOT-ov25 trials evaluating maintenance olaparib or bevacizumab or the combination of both in newly diagnosed, advanced BRCA-mutated ovarian cancer
11. Oral Ribavirin for Treatment of Respiratory Syncytial Virus in Lung Transplantation Recipients
12. Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project
13. Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
14. Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH)
15. Encuesta Nacional de la SEFH-2019: cartera de servicios, actividad asistencial, docencia e investigación en los Servicios de Farmacia Hospitalaria en España
16. An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study
17. Effect of adding fortifiers and protein supplements on the osmolality of donated maternal milk
18. Efecto de la adición de fortificantes y de módulo de proteínas en la osmolalidad de la leche materna donada
19. Supplementary Figure S1 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
20. Supplementary Table S2 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
21. Data from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
22. Supplementary Appendix S1 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
23. A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors
24. Management of advanced ovarian cancer in Spain: an expert Delphi consensus
25. Development and testing of a mobile app for systematic collection of patient-reported outcomes (PROs) in patients with hemophilia
26. Advancing clinical research globally: Cervical cancer research network from Mexico
27. Antimicrobial stewardship programme in critical care medicine: A prospective interventional study
28. High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial
29. Real-world analysis of the PK-guided switch from standard half-life factor VIII to efmoroctocog alfa
30. Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2
31. A randomized phase II non-comparative study of PF-04691502 and gedatolisib (PF-05212384) in patients with recurrent endometrial cancer
32. Aflibercept in exudative age related macular degeneration refractory to ranibizumab
33. Resultados de aflibercept en degeneración macular asociada a la edad refractaria a ranibizumab
34. Trans-arterial chemoembolization with doxorubicin-eluting particles versus conventional trans-arterial chemoembolization in unresectable hepatocellular carcinoma: A study of effectiveness, safety and costs
35. Quimioembolización transarterial con partículas liberadoras de doxorrubicina frente a quimioembolización transarterial convencional en carcinomas hepatocelulares irresecables: un estudio de eficacia, seguridad y gastos
36. Clinical evaluation of rituximab treatment for neuromyelitis optica
37. Evaluación del uso de rituximab en la neuromielitis óptica
38. Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
39. Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup
40. Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial
41. Clinical experiences with cannabinoids in spasticity management in multiple sclerosis
42. Experiencia clínica con los cannabinoides en la terapia de la espasticidad en la esclerosis múltiple
43. Nibrin is a marker of clinical outcome in patients with advanced serous ovarian cancer treated in the phase III OVA-301 trial
44. Mejora del proceso farmacoterapéutico del paciente hospitalizado mediante la metodología Lean Seis Sigma
45. Tall man lettering application in medication information systems as a quality and safety strategy in hospital organization
46. Evaluación de la hoja de información al paciente y del consentimiento informado en ensayos clínicos
47. 4CPS-176 Oral ivermectin effectiveness in the treatment of permethrin-resistant scabies: a descriptive and retrospective observational study
48. 4CPS-175 Medication regimen complexity index among solid organ transplant patients in a tertiary hospital
49. Pharmacotherapeutic management of advanced therapy medicinal products
50. SMPTall man lettering application in medication information systems as a quality and safety strategy in hospital organization
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.